Specimen index
Peptide Database
5 peptides — filtered results
GHRP-2
Phase IIPralmorelin · Growth Hormone-Releasing Peptide 2
GHRP-2 is a synthetic hexapeptide and potent ghrelin receptor agonist that stimulates growth hormone release from the pituitary. It produces a strong GH pulse with some elevation of cortisol and prolactin at higher doses. Research includes GH deficiency diagnosis, body composition, sleep quality, and appetite stimulation via its ghrelin-mimetic mechanism.
C₄₅H₅₅N₉O₆ · 817.99 Da
GHRP-6
PreclinicalGrowth Hormone-Releasing Peptide 6 · His-DTrp-Ala-Trp-DPhe-Lys-NH₂
GHRP-6 is one of the original synthetic GHRPs, acting as a strong ghrelin receptor agonist. It produces robust GH release accompanied by significant appetite stimulation — a property that makes it both valuable for cachexia research and distinct from cleaner GHRPs like Ipamorelin. Research also shows cytoprotective and cardioprotective properties independent of GH secretion.
C₄₆H₅₆N₁₂O₆ · 873.02 Da
Hexarelin
Phase IIExamorelin · EP 23905
Hexarelin is one of the most potent synthetic GHRP compounds, producing the largest GH pulse among GHRPs. Beyond its GH-stimulating properties, research highlights direct cardioprotective effects through CD36 receptor binding, independent of GH or IGF-1. Studies show benefits in heart failure models, myocardial infarction recovery, and protection against ventricular dysfunction.
Ipamorelin
PreclinicalNNC 26-0161
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Unlike other GHRPs, it stimulates GH release with high selectivity — producing minimal cortisol, ACTH, or prolactin elevation. It is among the most studied GHRPs for its clean GH pulse profile, making it a preferred research peptide for GH axis studies with reduced side effect concern.
C₃₈H₄₉N₉O₅ · 711.86 Da
Mod GRF 1-29
PreclinicalCJC-1295 without DAC · Modified GRF 1-29
Mod GRF 1-29 is a modified version of GHRH(1-29) with four amino acid substitutions that increase stability and half-life without the DAC albumin-binding component. It produces a natural, pulsatile GH release and is commonly paired with GHRPs (like Ipamorelin) for a synergistic GH pulse. Its shorter duration preserves natural pituitary feedback mechanisms.